Every year brings a “trends to watch” list, and most of them are recycled. This one is grounded specifically in regulatory deadlines, payer behavior, and technology shifts that are actually in motion right now, in the second half of 2026 — not evergreen generalities about “the shift to value-based care” that could have been written five years ago. If you run billing operations for a practice of any size, here’s what actually deserves a spot on your radar for the rest of this year and into 2027.
1. The CMS electronic prior authorization deadline is closing in
CMS’s interoperability and prior authorization rule requires impacted payers — including Medicare Advantage, Medicaid, CHIP, and QHP issuers on the federally facilitated exchanges — to build and support specific FHIR-based APIs for prior authorization, with a compliance deadline of January 1, 2027. That sounds distant, but payer and vendor system changes of this scope take months of testing, and practices that haven’t started asking their clearinghouse and EHR vendor how they’re preparing for the electronic prior-auth workflow risk finding out the hard way in early 2027 that their systems aren’t ready to use it.
2. AI-assisted prior authorization is now live in traditional Medicare
CMS’s WISeR model (Wasteful and Inappropriate Service Reduction) is testing AI-assisted prior authorization and pre-payment review for a defined set of services in a subset of states, and it’s drawn significant attention from KFF, Georgetown’s Center for Children and Families, and physician organizations because of what it signals: AI-assisted review is no longer confined to commercial payers. Billing teams in affected states need to understand which services and CPT/HCPCS codes are in scope and build the additional documentation discipline the model expects.
3. DMEPOS prior authorization keeps expanding
CMS’s Required Prior Authorization program for durable medical equipment, prosthetics, orthotics, and supplies has continued phasing in additional codes and states through 2026, with published effective dates in the spring and again in the fall of this year. DME billing teams need to check the current code list regularly rather than relying on a list from earlier in the year — codes and covered states have been added incrementally, not all at once.
4. Physicians are pushing back harder on AI-driven denials
2026 AMA survey data found that a majority of physicians believe AI is increasing prior authorization denials, and separate AMA reporting found deep skepticism — roughly one in three physicians trusting insurers’ reform pledges — about whether payers are actually following through on prior-auth reforms announced in 2025. Expect continued state-level legislative activity requiring licensed-clinician review of algorithmic denials, and expect payers to face growing pressure to disclose when and how AI tools were used in a specific determination.
5. The AI performance-vs-marketing gap is narrowing, but not closed
As covered elsewhere on this site, 2026 has been the year AI tools for claim scrubbing, denial-risk scoring, eligibility verification, and appeal drafting moved from pilot to production at a much wider range of practice sizes — not just large health systems. At the same time, “fully autonomous” claims about these tools remain mostly marketing; the practical reality is automation of routine, pattern-based work with human review still required for exceptions and anything with compliance exposure.
6. Hybrid team structures are becoming the norm, not the exception
Billing departments are increasingly organizing around a deliberate split — automation handling high-volume routine work, exception specialists handling flagged and complex cases, and a dedicated oversight function checking that the automation is still performing as expected. Practices that haven’t yet defined these lanes explicitly are more likely to either over-trust an automated tool or under-utilize one they’ve already paid for.
7. Price transparency enforcement keeps tightening
Hospital and payer price transparency requirements have continued to see enforcement activity and rulemaking attention in 2026, and No Surprises Act provisions remain an active source of billing disputes, particularly around good-faith estimates for self-pay and out-of-network scenarios. Billing teams handling self-pay patients need current, accurate estimate processes — this is an area regulators and patients are both watching closely.
8. Denial-appeal cycle times are shrinking, on both sides
As payers move faster on the front end with automated review, providers who still rely on slow, manual appeal drafting risk missing filing windows or losing leverage. The practices keeping pace are the ones that have adopted at least some automation on their own side — appeal-letter drafting assistance, automated status tracking — specifically to match the speed of an increasingly automated denial process, not to outsource judgment on the appeal’s substance.
9. Search and content rules are tightening for healthcare information sites
Less directly operational but worth knowing if your practice publishes patient-facing billing or health content: Google has continued reinforcing its guidance against mass-produced, low-value AI content (its “scaled content abuse” spam policy) throughout 2026, and rolled its generative AI performance reporting out to all Search Console properties worldwide as of the end of August. Any practice or RCM company publishing content online should understand these rules — genuinely useful, disclosed, human-reviewed content is treated very differently than bulk AI output with no added value.
10. Consolidation continues among RCM vendors
Established RCM and clearinghouse vendors have continued building AI-based detection and automation into their existing platforms — extending, rather than replacing, infrastructure many practices already use — while a wave of AI-native startups compete on narrower use cases like denial prediction or appeal drafting. Expect continued market consolidation and a widening gap between vendors validating their models against real claims outcomes and those relying primarily on marketing claims.
A practical calendar check
- Confirm your DME billing workflow reflects the current, most recently updated prior-authorization code list — not a list from earlier in 2026.
- Ask your clearinghouse and EHR vendor directly what their plan is for the January 1, 2027 electronic prior-auth API deadline.
- If you’re in a WISeR pilot state, verify your documentation practices align with what the model’s clinical reviewers are actually checking.
- Review your good-faith estimate process for self-pay patients against current No Surprises Act guidance.
Takeaway: 2026’s real trends aren’t abstract — they’re specific deadlines (January 1, 2027 for electronic prior auth), specific programs (WISeR, expanding DMEPOS prior auth), and a specific shift in how billing teams are organizing around AI. Build your calendar and your team structure around those concrete facts rather than generic “AI is changing everything” messaging.
Wondering when ICD-11 replaces this? See our ICD-11 U.S. transition status guide — spoiler: there’s no date set yet.
For a deeper look at billing-cost economics specifically, see our guide to what outsourcing medical billing actually costs in 2026.